Literature DB >> 20686908

Docking and 3D-QSAR modeling of cyclin-dependent kinase 5/p25 inhibitors.

Zaheer Ul Haq1, Reaz Uddin, Lam Kok Wai, Abdul Wadood, Nordin Haji Lajis.   

Abstract

Structure-based 3D-QSAR approaches (CoMFA and CoMSIA) were applied to understand the structural requirements of the Cyclin-dependent kinase 5/p25 inhibitors. Cyclin-dependent kinase 5 (CDK5) is believed to play an important role in the development of the central nervous system during the process of mammalian embryogenesis. Genetic algorithm based docking program (GOLD) was successfully utilized to orient the compounds inside the binding pocket of the CDK5/p25 structure. The adapted alignment method with the suitable parameters resulted in a reliable model. Furthermore, the final model was robust enough to forecast the activities of test compounds, satisfactorily. The contour maps were produced around the functional groups to understand the SAR requirements. Moreover, we also investigate the structural attributes of the inhibitors which make them selective toward CDK5/p25 over its close counterpart, i.e., CDK2. The study could be helpful to rationalize the new compounds with better inhibition and selectivity profiles against CDK5/p25.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20686908     DOI: 10.1007/s00894-010-0817-2

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  29 in total

1.  Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation.

Authors:  Araz Jakalian; David B Jack; Christopher I Bayly
Journal:  J Comput Chem       Date:  2002-12       Impact factor: 3.376

2.  Phage display screening against a set of targets to establish peptide-based sugar mimetics and molecular docking to predict binding site.

Authors:  Limin Yu; Peggy Shuang Yu; Elizabeth Yee Yen Mui; Jennifer C McKelvie; Thi Phuong Tu Pham; Yan Wen Yap; Wan Qing Wong; Jiawen Wu; Weiqiao Deng; Brendan P Orner
Journal:  Bioorg Med Chem       Date:  2009-04-01       Impact factor: 3.641

Review 3.  A decade of CDK5.

Authors:  R Dhavan; L H Tsai
Journal:  Nat Rev Mol Cell Biol       Date:  2001-10       Impact factor: 94.444

4.  Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons.

Authors:  J A Bibb; G L Snyder; A Nishi; Z Yan; L Meijer; A A Fienberg; L H Tsai; Y T Kwon; J A Girault; A J Czernik; R L Huganir; H C Hemmings; A C Nairn; P Greengard
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

Review 5.  Cyclin-dependent kinase 5 in amyotrophic lateral sclerosis.

Authors:  Minh Dang Nguyen; Jean-Pierre Julien
Journal:  Neurosignals       Date:  2003 Sep-Oct

Review 6.  Role of cdk5 in the pathogenesis of Alzheimer's disease.

Authors:  Lit-Fui Lau; Michael K Ahlijanian
Journal:  Neurosignals       Date:  2003 Sep-Oct

7.  Synthesis and biological activity of N-aryl-2-aminothiazoles: potent pan inhibitors of cyclin-dependent kinases.

Authors:  Raj N Misra; Hai-yun Xiao; David K Williams; Kyoung S Kim; Songfeng Lu; Kristen A Keller; Janet G Mulheron; Roberta Batorsky; John S Tokarski; John S Sack; S David Kimball; Francis Y Lee; Kevin R Webster
Journal:  Bioorg Med Chem Lett       Date:  2004-06-07       Impact factor: 2.823

8.  A novel approach to cyclin-dependent kinase 5/p25 inhibitors: A potential treatment for Alzheimer's disease.

Authors:  Mahendra Ramesh Shiradkar; Mallikarjuna Bandrehally Padhalingappa; Sastry Bhetalabhotala; Kalyan Chakravarthy Akula; Dattu Anna Tupe; Raghotham Reddy Pinninti; Suman Thummanagoti
Journal:  Bioorg Med Chem       Date:  2007-07-04       Impact factor: 3.641

9.  Structural investigations of acridine derivatives by CoMFA and CoMSIA reveal novel insight into their structures toward DNA G-quadruplex mediated telomerase inhibition and offer a highly predictive 3D-model for substituted acridines.

Authors:  Vishal P Zambre; Prashant R Murumkar; Rajani Giridhar; Mange Ram Yadav
Journal:  J Chem Inf Model       Date:  2009-05       Impact factor: 4.956

10.  Discovery of aminothiazole inhibitors of cyclin-dependent kinase 2: synthesis, X-ray crystallographic analysis, and biological activities.

Authors:  Kyoung Soon Kim; S David Kimball; Raj N Misra; David B Rawlins; John T Hunt; Hai-Yun Xiao; Songfeng Lu; Ligang Qian; Wen-Ching Han; Weifang Shan; Toomas Mitt; Zhen-Wei Cai; Michael A Poss; Hong Zhu; John S Sack; John S Tokarski; Chieh Ying Chang; Nikola Pavletich; Amrita Kamath; William G Humphreys; Punit Marathe; Isia Bursuker; Kristen A Kellar; Urvashi Roongta; Roberta Batorsky; Janet G Mulheron; David Bol; Craig R Fairchild; Francis Y Lee; Kevin R Webster
Journal:  J Med Chem       Date:  2002-08-29       Impact factor: 7.446

View more
  2 in total

1.  Discovery of thienoquinolone derivatives as selective and ATP non-competitive CDK5/p25 inhibitors by structure-based virtual screening.

Authors:  Arindam Chatterjee; Stephen J Cutler; Robert J Doerksen; Ikhlas A Khan; John S Williamson
Journal:  Bioorg Med Chem       Date:  2014-09-28       Impact factor: 3.641

2.  3D-QSPR method of computational technique applied on red reactive dyes by using CoMFA strategy.

Authors:  Uzma Mahmood; Sitara Rashid; S Ishrat Ali; Rasheeda Parveen; Nida Ambreen; Khalid Mohammed Khan; Shahnaz Perveen; Wolfgang Voelter
Journal:  Int J Mol Sci       Date:  2011-12-05       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.